Bionor Pharma Appoints Anker Lundemose as President and Chief Executive Officer
The Appointment Considerably Strengthens Bionor Pharma's Partnering Capabilities
OSLO, NORWAY--(Healthcare Sales & Marketing Network) - Bionor Pharma ASA ( OSLO : BIONOR ) today announced that Anker Lundemose, MD, PhD, DMSc (Medical Microbiology), has b...
Biopharmaceuticals, HIV/AIDS, Personnel
Bionor Pharma, Vacc-4x, vaccine
Biopharmaceuticals, HIV/AIDS, Personnel
Bionor Pharma, Vacc-4x, vaccine
Sanofi Launches Breakthrough Technology for Cardiovascular and Vascular Surgery Procedures
LeGoo® proprietary gel technology provides clear surgical field for cardiothoracic and vascular surgeons without trauma to blood vessels
BRIDGEWATER, N.J., Jan. 29, 2013 -- (Healthcare Sales & Marketing Network) -- Sanofi US announced the commercia...
Devices, Surgery, Product Launch
Sanofi, LeGoo, biopolymer gel, atraumatic occlusion, occlusion gel
Devices, Surgery, Product Launch
Sanofi, LeGoo, biopolymer gel, atraumatic occlusion, occlusion gel
Colibri Heart Valve Announces Issuance of a Patent for a Pre-mounted, Pre-packaged, Sterilized Dry Heart Valve on a Delivery System
BROOMFIELD, CO, Jan. 29, 2013 -- (Healthcare Sales & Marketing Network) -- Colibri Heart Valve, LLC, a privately held medical device company, has been granted yet another patent directed to prosthetic heart valves. More particularly, today the U.S. Patent ...
Devices, Interventional Cardiology
Colibri Heart Valve, TAVI system, transcatheter, heart valve, aortic valve
Devices, Interventional Cardiology
Colibri Heart Valve, TAVI system, transcatheter, heart valve, aortic valve
Spectranetics Announces Expansion Into Japan Peripheral Intervention Market
Market-Leading Quick-Cross(R) Support Catheter Receives Regulatory and Reimbursement Approval
COLORADO SPRINGS, Colo., Jan. 29, 2013 -- (Healthcare Sales & Marketing Network) -- The Spectranetics Corporation today announced regulatory and reimbursement ...
Devices, Interventional, Regulatory
Spectranetics, Quick-Cross, Support Catheter, peripheral artery disease
Devices, Interventional, Regulatory
Spectranetics, Quick-Cross, Support Catheter, peripheral artery disease
FDA Grants Soligenix Fast Track Designation for OrbeShield(TM) for the Reduction of Mortality Associated with Gastrointestinal Acute Radiation Syndrome (GI ARS)
PRINCETON, N.J., Jan. 29, 2013 -- (Healthcare Sales & Marketing Network) -- Soligenix, Inc. (SNGX) (Soligenix or the Company), a development stage biopharmaceutical company, announced today that its OrbeShieldTM (oral beclomethasone 17,21-dipropionate or ...
Biopharmaceuticals, FDA
Soligenix, OrbeShield, oral BDP, fast track designation, GI ARS
Biopharmaceuticals, FDA
Soligenix, OrbeShield, oral BDP, fast track designation, GI ARS
JointMetrix Medical Presents Novel Joint Monitoring Technology
Company is Pioneering use of Remote Monitoring in Orthopaedics
SEATTLE, Jan. 28, 2013 -- (Healthcare Sales & Marketing Network) -- JointMetrix Medical has developed novel remote monitoring technology for use in conjunction with joint replacement surger...
Devices, Orthopaedic, Monitoring
JointMetrix Medical, remote monitoring, joint replacement
Devices, Orthopaedic, Monitoring
JointMetrix Medical, remote monitoring, joint replacement
Ocular Therapeutix, Inc. Closes on $23.8 Million Series D Extension
BEDFORD, Mass.--(Healthcare Sales & Marketing Network)--Ocular Therapeutix, Inc. announced today it recently closed a Series D extension round of financing totaling $23.8 million. After considering offers from several new investors, the decision was made t...
Devices, Drug Delivery, Ophthalmology, Venture Capital
Ocular Therapeutix, drug-eluting punctum plug, ReSure Sealant
Devices, Drug Delivery, Ophthalmology, Venture Capital
Ocular Therapeutix, drug-eluting punctum plug, ReSure Sealant
New NCCN Guidelines for Patients(R) Available for Adolescents and Young Adults with Cancer
NCCN announces the availability of NCCN Guidelines for Patients®: Caring for Adolescents and Young Adults, a patient-friendly translation of the NCCN Guidelines® focused on people diagnosed with cancer between the ages of 15 and 39.
FORT WASHIN...
Biopharmaceuticals, Devices, Oncology
National Comprehensive Cancer Network, NCCN, young adults with cancer
Biopharmaceuticals, Devices, Oncology
National Comprehensive Cancer Network, NCCN, young adults with cancer
BrainStorm Cell Therapeutics Appoints Alon Natanson as Chief Executive Officer
NEW YORK & PETACH TIKVAH, Israel--(Healthcare Sales & Marketing Network)--BrainStorm Cell Therapeutics (BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, announced today that it has appointed Mr. Alon Natanson as it...
Regenerative Medicine, Neurology, Personnel
BrainStorm Cell Therapeutics, stem cell
Regenerative Medicine, Neurology, Personnel
BrainStorm Cell Therapeutics, stem cell
Cook Medical Introduces Flexor(R) Parallel(TM)
BLOOMINGTON, Ind.--(Healthcare Sales & Marketing Network)--The only Food and Drug Administration (FDA) approved ureteral access sheath that has two options for placement is now available in the United States. The Flexor® Parallel Rapid Release Ureter...
Devices, Urology, Product Launch
Cook Medical, Flexor Parallel, Ureteral Access Sheath
Devices, Urology, Product Launch
Cook Medical, Flexor Parallel, Ureteral Access Sheath

